Faculty profile

Meghan Aversa

Back to faculty

Assistant ProfessorDepartment of MedicineUniversity of Toronto

Meghan Aversa

Assistant Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
19 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

973

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2026
Variability in Lung Transplant Clinical Practices in Canada: Results of a National Survey.
Transplantation direct · 2026
Prolonged Invasive Mechanical Ventilation is Associated With Decreased Survival After Lung Transplantation Among Recipients With Primary Graft Dysfunction: A Lung Transplant Outcomes Group Study.
Clinical transplantation · 2026 · first author

All 23 publications

23 publications.

Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study.

Hall VG, Alexander AA, Mavandadnejad F, Kern-Smith M, Dang X, Kang R, Humar S, Winichakoon P, Johnstone R, Aversa M, Novitzky-Basso I, Lavoie PM, Kumar D, Mattsson J, Ferreira VH

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases202612 citationsOpen Access

DOI: 10.1016/j.cmi.2025.09.013 PMID: 41016596

Variability in Lung Transplant Clinical Practices in Canada: Results of a National Survey.

Michaels M, Kaur K, Weatherald J, Nagendran J, Aversa M, Nador R, Poirier C, Halloran K

Transplantation direct20262 citationsOpen Access

DOI: 10.1097/txd.0000000000001897 PMID: 41550295

Prolonged Invasive Mechanical Ventilation is Associated With Decreased Survival After Lung Transplantation Among Recipients With Primary Graft Dysfunction: A Lung Transplant Outcomes Group Study.

Aversa M, Keshavjee S, Martinu T, Cypel M, Sage AT, Diamond JM, Singer JP, Palmer SM, Pandya K, Cantu E, Christie JD, Anderson MR

Clinical transplantation20261 citationsFirst authorOpen Access

DOI: 10.1111/ctr.70447 PMID: 41532276

Lung transplantation for pulmonary alveolar proteinosis: a retrospective international multicentre analysis.

Schwarz S, Prosch H, Yekeler E, Solli P, Demant X, Hayes D, Chida M, Halloran K, Greer M, Garcha P, Ceulemans LJ, Lindstedt S, Merveilleux C, Reed RM, Musk M, Shtraichman O, Sanchez PG, Abdulqawi R, Sayah DM, Mora VM, Magnusson JM, Balaguer Cartagena MN, Zapata Gonzalez RA, Fisher AJ, Rosado J, Osses JM, Koch A, Reynolds JM, Picard C, El Husseini K, Aversa M, Kaza V, Benazzo A, Aigner C, Bonella F, Jaksch P, Hoetzenecker K

The European respiratory journal2026

DOI: 10.1183/13993003.02351-2025 PMID: 42425729

ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities.

Juvet S, Snell GI, Bos S, Budev MM, Greenland JR, Halloran K, Lindstedt S, Snyder LD, Abdulqawi R, Abedini A, Arcasoy SM, Aversa M, Benazzo A, Calabrese DR, Calabrese F, Cano M, Chan K, Chandrashekaran S, Darley D, Emtiazjoo A, Fallah T, Godinas L, Hage R, Hayes D, Huang HJ, Kleinerova J, Kotecha S, Kumar A, Lunardi F, Mallea J, Martinu T, Meloni F, Mohandas A, Morrell ED, Nair A, Novysedlak R, Perch M, Pezzuto F, Picard C, Riddell P, Roden AC, Rosenheck JP, Semenchuk J, Shah U, Strah H, Tague LK, Tomic R, Trindade AJ, Vandervest K, Verleden GM, Westall G, Shaver CM

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2026

DOI: 10.1016/j.healun.2026.02.1677 PMID: 42126382

A Perspective Summary of the ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD).

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2026

DOI: 10.1016/j.healun.2026.02.1676 PMID: 42236077

The NHLBI lung transplant consortium 2025 steering committee report: Strategies to maximize the use of the consortium for advancing lung transplantation.

Neely M, Mongodin E, Whitson BA, Hachem RR, Anderson MR, Frankel C, Oyster ML, Shaver CM, Morrell ED, Aversa M, Damman AM, Christie J, Palmer SM, Lung Transplant Consortium Investigators and Steering Committee

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2026

DOI: 10.1016/j.healun.2025.11.023 PMID: 41297730

Prolonged Preservation of up to 24 Hours at 10 °C Does Not Impact Outcomes after Lung Transplantation.

Hoetzenecker K, Ali A, Campo-Cañaveral de la Cruz J, Schwarz S, Crowley Carrasco S, Romero Roman A, Aladaileh M, Benazzo A, Jaksch P, Wakeam E, Aversa M, Keshavjee S, Cypel M

Annals of surgery202523 citationsOpen Access

DOI: 10.1097/sla.0000000000006632 PMID: 39817344

Humoral immunity to lung antigens early post-transplant confers risk for chronic lung allograft dysfunction.

Vosoughi D, Ulahannan A, Li Q, Huszti E, Chruscinski A, Birriel D, Madu G, Teskey G, Aversa M, Martinu T, Juvet S

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation20254 citationsOpen Access

DOI: 10.1016/j.healun.2025.02.1577 PMID: 39971216

Gastroesophageal reflux is a risk factor for the development of de novo donor specific antibodies after lung transplantation.

Bell P, Kiernan J, Ramendra R, Wang S, Huszti E, D'Ovidio F, Yeung J, Wakeam E, Cypel M, Keshavjee S, Juvet S, Singer L, Parker C, Liu L, Martinu T, Aversa M

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation20251 citationsSenior author

DOI: 10.1016/j.healun.2025.03.007 PMID: 40081629

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Meghan Aversa

Research

Latest papers

Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study.

Variability in Lung Transplant Clinical Practices in Canada: Results of a National Survey.

Prolonged Invasive Mechanical Ventilation is Associated With Decreased Survival After Lung Transplantation Among Recipients With Primary Graft Dysfunction: A Lung Transplant Outcomes Group Study.

Lung transplantation for pulmonary alveolar proteinosis: a retrospective international multicentre analysis.

ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities.

A Perspective Summary of the ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD).

The NHLBI lung transplant consortium 2025 steering committee report: Strategies to maximize the use of the consortium for advancing lung transplantation.

Prolonged Preservation of up to 24 Hours at 10 &#xb0;C Does Not Impact Outcomes after Lung Transplantation.

Humoral immunity to lung antigens early post-transplant confers risk for chronic lung allograft dysfunction.

Gastroesophageal reflux is a risk factor for the development of de novo donor specific antibodies after lung transplantation.

Frequent collaborators

Tereza Martinu

Marcelo Cypel

Shaf Keshavjee

Lianne Singer

Stephen Juvet

Kieran Halloran

Jonathan Yeung

Christopher Patriquin

Kathryn Tinckam

David Barth

Louis Liu

Andrew Sage

Mingyao Liu

Colleen Parker

Igor Novitzky-Basso

David Naimark

Laura Donahoe

Andrew Pierre

Karen Mcrae

Melinda Solomon

Kali Barrett

Charles Poirier

Marc de Perrot

Jason Weatherald

Shahid Husain

Victoria Hall

Victor Ferreira

Stephen Lapinsky

Eleanor Pullenayegum

Elliot Wakeam

Jayan Nagendran

Andrew Healey

Prolonged Preservation of up to 24 Hours at 10 °C Does Not Impact Outcomes after Lung Transplantation.